Migraine Medication Labeling Changes
Do you ever wonder if you have the most current information about your Migraine and headache medications? It can be difficult to keep up with the changes made to the labeling of medications.
Fortunately, the FDA's MedWatch program makes it easier to keep up. Each month, they publish a list of all updates and changes to medication labeling. In December, there were changes to the labeling for some of the medications we may take for our Migraines and headaches.
Below is a list of all medications that had labeling changes last month. I've included all of them in case you take medications for other conditions. To find the details of the labeling changes for any of the medications, just click on the name of the medication. There's also a key to what the various columns mean. The most serious changes will be the "BW," boxed warning changes.
The summary view includes drug products with safety labeling changes to the BOXED WARNING, CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, ADVERSE REACTIONS, or PATIENT PACKAGE INSERT/MEDICATION GUIDE sections. The “quick view” table below provides the drug name and sections modified. Click on the drug name to go to the detailed view. The detailed view includes sections and subsections modified, a description of new or modified safety information in the BOXED WARNING, CONTRAINDICATIONS, or WARNINGS sections, and a link to the revised prescribing information.
Key to Label Section Acronyms:
BW=BOXED WARNING, C=CONTRAINDICATIONS, W=WARNINGS, P=PRECAUTIONS, AR=ADVERSE REACTIONS, PPI/MG=PATIENT PACKAGE INSERT/MEDICATION GUIDE, PCI=PATIENT COUNSELING INFORMATION
Medical review by John Claude Krusz, PhD, MD.